Updated recommendations on the use of meningococcal vaccines
- PMID: 25070306
- DOI: 10.1542/peds.2014-1383
Updated recommendations on the use of meningococcal vaccines
Abstract
Since the last policy statement from the American Academy of Pediatrics (AAP) concerning meningococcal vaccine was published in 2011, 2 meningococcal conjugate vaccines have been licensed for use in infants (Hib-MenCY-TT and MenACWY-CRM). The Centers for Disease Control and Prevention (CDC) has published new recommendations, "Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices," which have been endorsed by the AAP. However, the CDC recommendations were published before licensure of MenACWY-CRM for infant use. This policy statement updates the AAP recommendations for use of meningococcal vaccines in children and adolescents. A more comprehensive review of background and technical information can be found in the CDC publication.
Keywords: adolescent vaccines; immunization schedule; meningococcal vaccine; meningococcus.
Copyright © 2014 by the American Academy of Pediatrics.
Similar articles
-
Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2013 Mar 22;62(RR-2):1-28. MMWR Recomm Rep. 2013. PMID: 23515099
-
Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):273. MMWR Morb Mortal Wkly Rep. 2010. PMID: 20224545
-
Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011.MMWR Morb Mortal Wkly Rep. 2011 Aug 5;60(30):1018-9. MMWR Morb Mortal Wkly Rep. 2011. PMID: 21814165
-
MenACWY-TT vaccine for active immunization against invasive meningococcal disease.Expert Rev Vaccines. 2012 May;11(5):523-37. doi: 10.1586/erv.12.32. Expert Rev Vaccines. 2012. PMID: 22827239 Review.
-
Recent trends in meningococcal epidemiology and current vaccine recommendations.Curr Opin Pediatr. 2006 Feb;18(1):58-63. doi: 10.1097/01.mop.0000193265.78506.7f. Curr Opin Pediatr. 2006. PMID: 16470164 Review.
Cited by
-
Epidemic forecast and preparedness for explosive-cerebrospinal meningitis outbreak in Nigeria using the preventive vaccination strategy.Afr J Lab Med. 2023 Nov 17;12(1):2086. doi: 10.4102/ajlm.v12i1.2086. eCollection 2023. Afr J Lab Med. 2023. PMID: 38058850 Free PMC article. Review.
-
Meningococcal Vaccinations.Infect Dis Ther. 2016 Jun;5(2):89-112. doi: 10.1007/s40121-016-0107-0. Epub 2016 Apr 16. Infect Dis Ther. 2016. PMID: 27086142 Free PMC article. Review.
-
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.BMJ. 2015 Apr 1;350:h1554. doi: 10.1136/bmj.h1554. BMJ. 2015. PMID: 25832102 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous